About this trial
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
Eligibility criteria
Qualifiers
Age ≥ 65 years
Policyholder in Austria (active unique social insurance number)
Written electronic informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Smartphone-based digital atrial fibrillation screening and management pathway
Treatment groups
Sponsors and collaborators
Medical University Innsbruck
Lead sponsor
AIT Austrian Institute of Technology GmbH
Collaborator
Medical University of Graz
Collaborator
UMIT Tirol
Collaborator